中國東北地區(qū)肢帶型肌營養(yǎng)不良癥
發(fā)布時(shí)間:2024-05-09 01:24
背景: 肢帶型肌營養(yǎng)不良癥LGMD是一組以肢帶肌受累為共同特征的疾病,但因其臨床表現(xiàn)各異,一些研究者對(duì)其學(xué)術(shù)定義的合理性尚有爭(zhēng)議。本文將從研究歷史、疾病分類、病理生理、診斷、預(yù)防、治療及未來研究前景幾個(gè)方面對(duì)本病進(jìn)行闡述;并對(duì)那些使這類遺傳病從理論研究走向臨床應(yīng)用的新技術(shù)和在動(dòng)物模型上取得令人難以置信的恢復(fù)的研究予以特別關(guān)注?傊,在過去的幾十年間LGMD研究進(jìn)展迅速。隨著研究團(tuán)隊(duì)的增多,世界范圍內(nèi)的患者登記、對(duì)患者的定期隨訪、LGMD亞型診斷標(biāo)準(zhǔn)的完善以及對(duì)LGMD病理生理過程認(rèn)識(shí)的不斷深入,相信接下來幾年,我們將切實(shí)改善本病的轉(zhuǎn)歸。同時(shí)我們對(duì)中國的LGMD情況及其分子診斷和病理生理學(xué)研究進(jìn)展也給予特別的介紹。 歷史上,Walton和Nattrass在1954年首次以肢帶型肌營養(yǎng)不良來命名這樣一組疾。耗信砂l(fā)。煌ǔT30歲以內(nèi)起;首發(fā)表現(xiàn)為肩胛部、骨盆及軀干肌肉罕見假性肥大,但面肌常不受累;病情進(jìn)展相對(duì)緩慢;遺傳方式為常染色體隱性遺傳。1995年歐洲神經(jīng)肌病中心工作組制定了更嚴(yán)格的LGMD診斷和分類標(biāo)準(zhǔn)。根據(jù)遺傳學(xué)特征將不同的LGMD亞型分組。 LGMD不是同質(zhì)性疾病,我們可...
【文章頁數(shù)】:210 頁
【學(xué)位級(jí)別】:博士
【文章目錄】:
中文摘要
Abstract
Chapter1 Introduction
1.1 -Research Significance
1.2 -Research Objectives
1.3 -Research questions
1.4 -Anticipated research contribution
1.4.1 -contribution to research
1.4.2 -contribution to clinic
1.5 -Thesis structure
Chapter2 Limb-Girdle Muscular Dystrophies:Where Next after Six Decades of FirstProposal?(Literature Review)
2.1 -Introduction
2.2 -Historical background
2.3 -Definition
2.4 -Mechanism of action
2.5 -pathophysiology
2.6 -New disease markers
2.7 -Disease Prevalence
2.8 -Genotype-phenotype correlation
2.9 -Diagnostic strategy
2.9.1 -Clinical
2.9.2 -Biochemical,imaging and electrophysiological studies
2.9.3 -Muscle biopsy:Light,confocal and electron microscopy
2.9.4 -Immunohistochemistry(IHC)and western blot(WB)assays
2.9.5 -Genetic diagnosis
2.10 -Prevention & Surveillance
2.11 -Management
2.12 -LGMD in China
2.13 -Conclusion
2.14 -Future perspectives
Chapter3 Certain Morphological Features in Limb-Girdle Muscular Dystrophies Are NotShared by Polymyositis:Useful Diagnostic Clues
3.1 -Introduction
3.2 -Materials and Methods
3.2.1 -patients
3.2.2 -Muscle biopsies
3.2.3 -Statistical analysis
3.3 -Results
3.4 -Discussion
3.5 -conclusion
3.6 -Future perspectives
Chapter4 Limb-girdle Muscular Dystrophy Subtypes:Un-preceded Cohort inNortheastern Chinese Population
4.1 -Introduction
4.2 -Subjects and methods
4.2.1 -Design
4.2.2 -Time and settings
4.2.3 -Subjects
4.2.4 -Methods(See Chapter 2 methods for full details)
4.3. Results
4.3.1 -Quantitative analysis of subjects
4.3.2 -protein analyses
4.3.3 -Clinical features
4.3.4 -Pathological features
4.3.5 -laboratory results
4.4 -Discussion
4.4.1 -Immunohistochemistry and immunoblot
4.4.2 -Statistics
4.4.3 -CliniCal Features
4.4.4 -Morphologically
4.4.5 -Biochemically
4.4.6 -Novel findings
4.5 -Conclusion
4.6 -Future perspectives
Chapter5 Dysferlinopathies in Northeastern China:Genetically Confirmed Cases fromHan Chinese Ethnicity
5.1 -Introduction
5.2 -Methods(See Chapter 2 methods for full details)
5.2.1 -Muscle biopsies
5.2.2 -Immunohistochemistry
5.2.3 -immunoblot
5.2.4 -Blot analysis
5.2.5 -Gene mutation analysis
5.3 -Materials
Patients
5.4 -Results
5.4.1 -Clinical features
5.4.2 -Muscle biopsies
5.4.3 -Protein testing
5.4.4 -Mutation screening results
5.5 -Discussion
5.6 -conclusion
5.7 -Future perspectives
Summary
Novel findings
References
Appendixes
Appendix 1
Appendix 2
Appendix 3
Curriculum vitae
Personal information
Education
Certificate of training course
Publications
Acknowledgments
本文編號(hào):3968111
【文章頁數(shù)】:210 頁
【學(xué)位級(jí)別】:博士
【文章目錄】:
中文摘要
Abstract
Chapter1 Introduction
1.1 -Research Significance
1.2 -Research Objectives
1.3 -Research questions
1.4 -Anticipated research contribution
1.4.1 -contribution to research
1.4.2 -contribution to clinic
1.5 -Thesis structure
Chapter2 Limb-Girdle Muscular Dystrophies:Where Next after Six Decades of FirstProposal?(Literature Review)
2.1 -Introduction
2.2 -Historical background
2.3 -Definition
2.4 -Mechanism of action
2.5 -pathophysiology
2.6 -New disease markers
2.7 -Disease Prevalence
2.8 -Genotype-phenotype correlation
2.9 -Diagnostic strategy
2.9.1 -Clinical
2.9.2 -Biochemical,imaging and electrophysiological studies
2.9.3 -Muscle biopsy:Light,confocal and electron microscopy
2.9.4 -Immunohistochemistry(IHC)and western blot(WB)assays
2.9.5 -Genetic diagnosis
2.10 -Prevention & Surveillance
2.11 -Management
2.12 -LGMD in China
2.13 -Conclusion
2.14 -Future perspectives
Chapter3 Certain Morphological Features in Limb-Girdle Muscular Dystrophies Are NotShared by Polymyositis:Useful Diagnostic Clues
3.1 -Introduction
3.2 -Materials and Methods
3.2.1 -patients
3.2.2 -Muscle biopsies
3.2.3 -Statistical analysis
3.3 -Results
3.4 -Discussion
3.5 -conclusion
3.6 -Future perspectives
Chapter4 Limb-girdle Muscular Dystrophy Subtypes:Un-preceded Cohort inNortheastern Chinese Population
4.1 -Introduction
4.2 -Subjects and methods
4.2.1 -Design
4.2.2 -Time and settings
4.2.3 -Subjects
4.2.4 -Methods(See Chapter 2 methods for full details)
4.3. Results
4.3.1 -Quantitative analysis of subjects
4.3.2 -protein analyses
4.3.3 -Clinical features
4.3.4 -Pathological features
4.3.5 -laboratory results
4.4 -Discussion
4.4.1 -Immunohistochemistry and immunoblot
4.4.2 -Statistics
4.4.3 -CliniCal Features
4.4.4 -Morphologically
4.4.5 -Biochemically
4.4.6 -Novel findings
4.5 -Conclusion
4.6 -Future perspectives
Chapter5 Dysferlinopathies in Northeastern China:Genetically Confirmed Cases fromHan Chinese Ethnicity
5.1 -Introduction
5.2 -Methods(See Chapter 2 methods for full details)
5.2.1 -Muscle biopsies
5.2.2 -Immunohistochemistry
5.2.3 -immunoblot
5.2.4 -Blot analysis
5.2.5 -Gene mutation analysis
5.3 -Materials
Patients
5.4 -Results
5.4.1 -Clinical features
5.4.2 -Muscle biopsies
5.4.3 -Protein testing
5.4.4 -Mutation screening results
5.5 -Discussion
5.6 -conclusion
5.7 -Future perspectives
Summary
Novel findings
References
Appendixes
Appendix 1
Appendix 2
Appendix 3
Curriculum vitae
Personal information
Education
Certificate of training course
Publications
Acknowledgments
本文編號(hào):3968111
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/3968111.html
最近更新
教材專著